Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more
Accuray Incorporated (ARAY) - Total Assets
Latest total assets as of December 2025: $448.01 Million USD
Based on the latest financial reports, Accuray Incorporated (ARAY) holds total assets worth $448.01 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Accuray Incorporated - Total Assets Trend (2002–2025)
This chart illustrates how Accuray Incorporated’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Accuray Incorporated - Asset Composition Analysis
Current Asset Composition (June 2025)
Accuray Incorporated's total assets of $448.01 Million consist of 67.5% current assets and 32.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.2% |
| Accounts Receivable | $97.87 Million | 20.8% |
| Inventory | $141.02 Million | 30.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $15.00K | 0.0% |
| Goodwill | $57.80 Million | 12.3% |
Asset Composition Trend (2002–2025)
This chart illustrates how Accuray Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Accuray Incorporated's current assets represent 67.5% of total assets in 2025, an increase from 17.3% in 2002.
- Cash Position: Cash and equivalents constituted 12.2% of total assets in 2025, down from 17.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 30.0% of total assets.
Accuray Incorporated Competitors by Total Assets
Key competitors of Accuray Incorporated based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Accuray Incorporated - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Accuray Incorporated generates 0.98x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Accuray Incorporated is currently not profitable relative to its asset base.
Accuray Incorporated - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.47 | 1.62 | 1.86 |
| Quick Ratio | 0.71 | 0.88 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $92.95 Million | $ 124.44 Million | $ 166.25 Million |
Accuray Incorporated - Advanced Valuation Insights
This section examines the relationship between Accuray Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.14 |
| Latest Market Cap to Assets Ratio | 0.10 |
| Asset Growth Rate (YoY) | 0.3% |
| Total Assets | $470.24 Million |
| Market Capitalization | $45.01 Million USD |
Valuation Analysis
Below Book Valuation: The market values Accuray Incorporated's assets below their book value (0.10 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Accuray Incorporated's assets grew by 0.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Accuray Incorporated (2002–2025)
The table below shows the annual total assets of Accuray Incorporated from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $470.24 Million | +0.34% |
| 2024-06-30 | $468.63 Million | -2.21% |
| 2023-06-30 | $479.21 Million | +1.35% |
| 2022-06-30 | $472.85 Million | -1.51% |
| 2021-06-30 | $480.10 Million | -2.21% |
| 2020-06-30 | $490.93 Million | +12.04% |
| 2019-06-30 | $438.18 Million | +15.70% |
| 2018-06-30 | $378.73 Million | -6.82% |
| 2017-06-30 | $406.46 Million | -13.34% |
| 2016-06-30 | $469.03 Million | -0.20% |
| 2015-06-30 | $469.97 Million | -5.09% |
| 2014-06-30 | $495.19 Million | +4.05% |
| 2013-06-30 | $475.93 Million | +0.58% |
| 2012-06-30 | $473.17 Million | +3.81% |
| 2011-06-30 | $455.78 Million | +73.18% |
| 2010-06-30 | $263.18 Million | -4.08% |
| 2009-06-30 | $274.39 Million | -6.99% |
| 2008-06-30 | $295.00 Million | -11.17% |
| 2007-06-30 | $332.11 Million | +139.58% |
| 2006-06-30 | $138.62 Million | +59.59% |
| 2005-06-30 | $86.86 Million | +168.53% |
| 2003-06-30 | $32.35 Million | +171.25% |
| 2002-06-30 | $11.93 Million | -- |